best emerging cryptocurrency 2021 Top stories

6 Lianban Yibin Paper: The company's current P/B ratio is quite different from that of the same industry. Yibin Paper announced the abnormal fluctuation of stock trading. Since December 6, 2024, the company's stock has been trading daily for six consecutive trading days, with a cumulative increase of 77.12%. According to the data released by CSI official website, the latest P/B ratio of papermaking and packaging owned by the company is 1.69 times, and the latest P/B ratio of the company is 9.28 times. The current P/B ratio of the company is quite different from that of the same industry. Investors are advised to pay attention to risks.Pacific Securities: Goldwind Technology's performance is expected to achieve rapid growth, with the first "buy" rating. Pacific Securities Research Report pointed out that with the profit recovery of wind turbine business and the contribution of wind farm investment and development and wind power service business, Goldwind Technology's (002202.SZ) performance is expected to achieve rapid growth. The first coverage gives a "buy" rating. Goldwind Technology has ranked first in the domestic wind power market for 13 consecutive years since 2011; However, in recent years, under the strong competitive pressure of wind turbine enterprises after the second line, their market share has declined. In the future, with the increase of market concentration, Goldwind Technology, as a leader, is expected to increase its share. At the end of the third quarter of 2024, the company's external order volume was 41.38GW, and sufficient in-hand order volume supported its share increase.Director of the International Energy Agency (IEA): Geothermal energy is suitable for providing a large amount of stable energy for data centers. The IEA said on Friday that shale drilling technology, which has led to a sharp increase in oil and gas production, has also stimulated the development of geothermal energy. In theory, geothermal energy can provide a stable power source equivalent to the total demand of India and the United States. Fatih Birol, director of the International Energy Agency, said after the agency released its first report on geothermal energy that geothermal energy is suitable for providing a large amount of stable energy for data centers. Birol said: "One of the demands for geothermal energy is the demand for electricity in data centers. The demand for data centers in the United States is great, and they need all-weather electricity, which makes geothermal very suitable. " Birol said that unlike renewable energy such as wind energy and solar energy, geothermal energy can be a sustainable energy source, but it is still in its infancy and needs a lot of investment and support from the government. The incoming Trump administration said it would promote more oil and gas drilling and hoped to reduce the green energy plan, but Birol saw no reason not to increase the use of geothermal energy. According to the data of the International Energy Agency, by 2050, the global geothermal heating may increase to 800 GW, accounting for 15% of the global demand growth, and the annual output is equivalent to the current total demand of the United States and India. According to the report of the International Energy Agency, global investment will exceed $1 trillion by 2035 and $2.8 trillion by 2050, of which about 75% will be invested in power generation facilities.

The U.S. House of Representatives passed a bill to expand the judiciary.The retail price of refined oil may end up stranded. According to calculation, as of the seventh working day on December 13th, the average price of reference crude oil varieties was 70.58 USD/barrel, with a change rate of -0.87%, and the corresponding domestic retail price of gasoline and diesel should be lowered by 40 yuan/ton. At 24: 00 on December 18th, it is the last price adjustment window of the retail price in 2024, so the retail price is likely to end stranded. By December 13th, 2024, the domestic retail price of gasoline and diesel had experienced "9 up, 9 down and 6 stranded". After the fluctuation offset, gasoline and diesel (standard products) were reduced by 115 yuan/ton and 125 yuan/ton respectively. (Jin Lianchuang)Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.

HKEx: HSBC repurchased 527,200 shares for HK$ 39.4 million on December 12.Zhengrong Real Estate and others were forced to execute 230 million yuan. According to the information of legal proceedings, recently, Zhengrong Real Estate Holdings Co., Ltd. and Minhou Zhenghong Real Estate Development Co., Ltd. added a piece of information about the person to be executed, with an execution target of more than 230 million yuan. The enforcement court is Fuzhou Intermediate People's Court of Fujian Province.Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.